B Quiet: Autoantigen-Specific Strategies to Silence Raucous B Lymphocytes and Halt Cross-Talk with T Cells in Type 1 Diabetes

Islet autoantibodies are the primary biomarkers used to predict type 1 diabetes (T1D) disease risk. They signal immune tolerance breach by islet autoantigen-specific B lymphocytes. T-B lymphocyte interactions that lead to expansion of pathogenic T cells underlie T1D development. Promising strategies...

Descripción completa

Detalles Bibliográficos
Autores principales: Felton, Jamie L., Conway, Holly, Bonami, Rachel H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824835/
https://www.ncbi.nlm.nih.gov/pubmed/33418839
http://dx.doi.org/10.3390/biomedicines9010042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824835/
https://www.ncbi.nlm.nih.gov/pubmed/33418839
http://dx.doi.org/10.3390/biomedicines9010042

Ejemplares similares